Kathryn S. Ivy

Statistics

Publications

Citations

113

H-Index

Active since

2015

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kathryn S. Ivy is an author at Memorial Sloan Kettering Cancer Center specializing in therapeutic tyrosine kinase inhibitors, tyrosine kinase inhibitors, and cancer pharmacology.

Publications per year

2015–2015

Publications

Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma

Parag P. Patwardhan, Kathryn S. Ivy, Elgilda Musi et al. · Oncotarget · 2015 · 113 citations · Full text

Medicine, Oncology, Pharmacology +14

1–1 of 1